Pricing Log in Create free account

Cellectar Biosciences, Inc. (CLRB) vs Phio Pharmaceuticals Corp. (PHIO)

Cellectar Biosciences, Inc. and Phio Pharmaceuticals Corp. are both Biotechnology companies. Cellectar Biosciences, Inc. and Phio Pharmaceuticals Corp. are of similar size ($11.2M and $10.8M). Across the 9 metrics below, Phio Pharmaceuticals Corp. leads on 6 and Cellectar Biosciences, Inc. on 3.

Valuation

Metric CLRB PHIO Biotechnology median
P/E n/m n/m 8.50
P/S n/m 74.31 9.71
P/B 0.47 0.80 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.84 0.20 0.64
EV/Sales n/m (19.55) 9.21
Earnings yield (336.84%) (148.28%) (33.15%)
Free cash flow yield (140.17%) (120.77%) (25.50%)

Profitability

Metric CLRB PHIO Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (125.99%) (113.71%) (56.36%)
Return on assets (88.70%) (100.78%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLRB PHIO Biotechnology median
Revenue growth (TTM) — 78.95% 6.02%
EPS growth (last fiscal year) 80.14% 84.03% 30.26%
Revenue growth, 5-year CAGR — (21.62%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLRB PHIO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.66 8.39 4.72
Net debt to EBITDA 0.58 2.28 0.96

Dividend

Metric CLRB PHIO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CLRB PHIO Biotechnology median
Market cap 11.24m 10.75m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack